Aripiprazole versus ziprasidone for schizophrenia
Hongling Yang, Jiangang Zheng, Bin Li, Sai Zhao, Wei Zheng
Abstract
Hongling Yang, Jiangang Zheng, Bin Li, Sai Zhao, Wei Zheng
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare the clinical efficacy and safety of aripiprazole versus ziprasidone for the treatment of people with schizophrenia.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare the clinical efficacy and safety of aripiprazole versus ziprasidone for the treatment of people with schizophrenia.
Key concepts: Ziprasidone, Aripiprazole, Schizophrenia (object-oriented programming), Psychiatry, Psychology, Medicine, Antipsychotic